Archive
Here you can find the archive of all Press Releases prior to 2018
Filter by date:
Showing 647 press releases before 2018
-
AstraZeneca and Aspen enter agreement for remaining rights to anaesthetics medicines
-
AstraZeneca presents new results identifying severe asthma patients who would benefit most from benralizumab
-
AstraZeneca presents superior progression-free survival for Imfinzi in the PACIFIC trial of patients with locally-advanced unresectable lung cancer at ESMO 2017 Congress
-
AstraZeneca’s Tagrisso shows potential as a new standard of care in 1st-line EGFR-mutated lung cancer at ESMO 2017 Congress
-
Celgene and AstraZeneca provide update on the FUSION clinical trial programme
-
Duaklir significantly improves lung function in COPD patients
-
Tezepelumab significantly reduced asthma exacerbations for a broad population of patients with severe uncontrolled asthma
-
AstraZeneca to present data on next generation of biologics at European Respiratory Society International Congress 2017
-
AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress
-
AstraZeneca and Takeda establish collaboration to develop and commercialise MEDI1341 for Parkinson’s disease
Latest articles and press releases
All of our latest press releases and articles are available to explore
Contact us
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Rob Skelding
Director Global Media Relations (Oncology)
+44 203 749 5821
Rebecca Einhorn
Director Global Media Relations (Oncology)
+1 301 398 1802
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
